Lactylation shields S100A11 from degradation to promote gastric cancer metastasis
Cellular Oncology · 2026
DOI: 10.1007/s13402-026-01255-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, 2026. Verfasst von Qingrui Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, China-Japan Friendship Hospital, No. 2, Yinghua East Road, Chaoyang District, Beijing, 100029, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, S100 Proteins, Proteolysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Protein lactylation, a novel post-translational modification utilizing lactate as the substrate, has emerged as a key mechanism linking metabolic alterations to cancer progression. This study aims to investigate the role and underlying mechanism of S100A11 lactylation in gastric cancer progression and metastasis.
Methods
Lactylome profiling, site-directed mutagenesis, co-IP, cycloheximide chase, ubiquitination assays, and in vitro/in vivo functional experiments were performed to dissect the regulatory effect of S100A11 lactylation.
Results
S100A11 was identified as a hyperlactylated protein in gastric cancer tissues, with lysine 27 (K27) and lysine 55 (K55) serving as the primary modification sites. Mechanistically, lactylation at K27 and K55 disrupted the interaction between S100A11 and its E3 ubiquitin ligase FBXW11, thereby inhibiting polyubiquitination and proteasomal degradation of the protein. The K27R/K55R double mutation, which abolished both lactylation and ubiquitination at these residues, resulted in constitutive stabilization of S100A11. The stabilized S100A11 hyperactivated the PI3K-AKT and ERK1/2 signaling cascades and upregulated the downstream oncogenic effectors Cyclin D1 and c-Myc. Functionally, S100A11 stabilization significantly enhanced the proliferation, colony formation, migration and invasion of gastric cancer cells in vitro, and markedly promoted lung metastasis in vivo. Clinically, higher lactylation levels of S100A11 were observed in patients with advanced TNM stages.
Conclusion
This study reveals a lactylation-ubiquitination competitive regulatory mechanism that governs S100A11 protein stability, which directly links Warburg effect-derived lactate to oncogenic protein stabilization and metastatic progression in gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, China-Japan Friendship Hospital, No. 2, Yinghua East Road, Chaoyang District, Beijing, 100029, China.
- China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100029, China.
- Department of Pathology, Beijing Huairou Hospital, Beijing, 101400, China.
- Department of General Surgery, China-Japan Friendship Hospital, Beijing, 100029, China.
- Department of Gastroenterology, China-Japan Friendship Hospital, No. 2, Yinghua East Road, Chaoyang District, Beijing, 100029, China. dushiyu1975@126.com.
Zitieren
APA
Zhang, Q., Zhou, Y., Wang, F., Yan, J., Liu, J., Zhang, L., & Du, S. (2026). Lactylation shields S100A11 from degradation to promote gastric cancer metastasis. Cellular Oncology. https://doi.org/10.1007/s13402-026-01255-w
Vancouver
Zhang Q, Zhou Y, Wang F, Yan J, Liu J, Zhang L, et al. Lactylation shields S100A11 from degradation to promote gastric cancer metastasis. Cellular Oncology. 2026. doi:10.1007/s13402-026-01255-w
BibTeX
@article{Zhang2026,
author = {Zhang, Qingrui and Zhou, Yuhang and Wang, Fangning and Yan, Jingrui and Liu, Jiayu and Zhang, Lin and Du, Shiyu},
title = {Lactylation shields S100A11 from degradation to promote gastric cancer metastasis},
journal = {Cellular Oncology},
year = {2026},
doi = {10.1007/s13402-026-01255-w}
}
EUVIMED